Alembic Pharmaceuticals receives PAS approval from USFDA for Pregabalin capsules
Pregabalin Capsules have an estimated market size of US $244 million for twelve months ending Sep 2022 according to IQVIA
Pregabalin Capsules have an estimated market size of US $244 million for twelve months ending Sep 2022 according to IQVIA
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed
Micafungin for Injection had annual sales of US $99 million in the United States according to IQVIA data
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery
Lacosamide Injection is used to treat partial-onset seizures.
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The drug is indicated for use in combination with other drugs
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
Subscribe To Our Newsletter & Stay Updated